Hydrocodone Bitartrate And Acetaminophen

HYDROCODONE BITARTRATE AND ACETAMINOPHEN- hydrocodone bitartrate and acetaminophen tablet
Aidarex Pharmaceuticals LLC

BOXED WARNING

Hepatotoxicity: Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product.

DESCRIPTION

Hydrocodone bitartrate and acetaminophen is supplied in tablet form for oral administration.

Hydrocodone bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder. It is affected by light. The chemical name is 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5). It has the following structural formula:

This is an image of the structural formula of Hydrocodone bitartrate.
(click image for full-size original)

Acetaminophen, 4′-hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:

This is an image of the structural formula of Acetaminophen.
(click image for full-size original)

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 2.5 mg/500 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 2.5 mg
Acetaminophen ……………………. 500 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch, croscarmellose sodium, FD&C Red #3, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, stearic acid, and sucrose. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 5 mg/325 mg

Each tablet contains:

Hydrocodone Bitartrate …………….. 5 mg
Acetaminophen ……………………….. 325 mg

In addition, each tablet contains the following inactive ingredients: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, sodium lauryl sulfate, stearic acid and sugar spheres which are composed of starch derived from corn, FD&C Red #40, FD&C Yellow #6, and sucrose. Meets USP Dissolution Test 2.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 5 mg/500 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 5 mg
Acetaminophen ……………………. 500 mg

In addition each tablet contains the following inactive ingredients: hypromellose, lactose monohydrate, magnesium stearate, and sodium starch glycolate. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/325 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 7.5 mg
Acetaminophen ……………………. 325 mg

In addition, each tablet contains the following inactive ingredients: croscarmellose sodium, FD&C Red #40 aluminum lake, FD&C Yellow #6 aluminum lake, lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, sodium lauryl sulfate, and stearic acid. Meets USP Dissolution Test 2.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/500 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 7.5 mg
Acetaminophen ……………………. 500 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, corn starch, croscarmellose sodium, FD&C Blue #1, FD&C Yellow #5, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, stearic acid, and sucrose. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/650 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 7.5 mg
Acetaminophen ……………………. 650 mg

In addition each tablet contains the following inactive ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 7.5 mg/750 mg

Each tablet contains:

Hydrocodone Bitartrate …………. 7.5 mg
Acetaminophen ……………………. 750 mg

In addition each tablet contains the following inactive ingredients: croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg

Each tablet contains:

Hydrocodone Bitartrate ………… 10 mg
Acetaminophen ……………………. 325 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, D&C Yellow #10 lake, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg

Each tablet contains:

Hydrocodone Bitartrate ………… 10 mg
Acetaminophen ……………………. 500 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, D&C Red #27 aluminum lake, D&C Red #30 aluminum lake, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/650 mg

Each tablet contains:

Hydrocodone Bitartrate ………… 10 mg
Acetaminophen ……………………. 650 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, FD&C Blue #1 aluminum lake, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/660 mg

Each tablet contains:

Hydrocodone Bitartrate ………… 10 mg Acetaminophen ……………………. 660 mg

In addition each tablet contains the following inactive ingredients: colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. May also contain crospovidone. Meets USP Dissolution Test 1.

CLINICAL PHARMACOLOGY

Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these involve the central nervous system and smooth muscle. The precise mechanism of action of hydrocodone and other opiates is not known, although it is believed to relate to the existence of opiate receptors in the central nervous system. In addition to analgesia, narcotics may produce drowsiness, changes in mood and mental clouding.

The analgesic action of acetaminophen involves peripheral influences, but the specific mechanism is as yet undetermined. Antipyretic activity is mediated through hypothalamic heat regulating centers. Acetaminophen inhibits prostaglandin synthetase. Therapeutic doses of acetaminophen have negligible effects on the cardiovascular or respiratory systems; however, toxic doses may cause circulatory failure and rapid, shallow breathing.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.